|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. Ca Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Colombet M, Soerjomataram I,
Dyba T, Randi G, Bettio M, Gavin A, Visser O and Bray F: Cancer
incidence and mortality patterns in Europe: Estimates for 40
countries and 25 major cancers in 2018. Eur J Cancer. 103:356–387.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cao M and Chen W: Epidemiology of lung
cancer in China. Thorac Cancer. 10:3–7. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Richard PJ and Rengan R: Oligometastatic
non-small-cell lung cancer: Current treatment strategies. Lung
Cancer (Auckl). 7:129–140. 2016.PubMed/NCBI
|
|
6
|
Fischer C, Leithner K, Wohlkoenig C,
Quehenberger F, Bertsch A, Olschewski A, Olschewski H and Hrzenjak
A: Panobinostat reduces hypoxia-induced cisplatin resistance of
non-small cell lung carcinoma cells via HIF-1α destabilization. Mol
Cancer. 14:42015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lakshmi SP, Reddy AT, Banno A and Reddy
RC: PPAR agonists for the prevention and treatment of lung cancer.
Ppar Res. 2017:82527962017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mohamad N, Jayalakshmi P, Rhodes A, Liam
CK, Tan JL and Yousoof S: Anaplastic lymphoma kinase (ALK)
mutations in patients with adenocarcinoma of the lung. Br J Biomed
Sci. 74:176–180. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Virmani AK and Gazdar AF: Tumor suppressor
genes in lung cancer. Methods Mol Biol. 222:97–115. 2003.PubMed/NCBI
|
|
10
|
Ghafouri-Fard S, Shoorei H, Branicki W and
Taheri M: Non-coding RNA profile in lung cancer. Exp Mol Pathol.
114:1044112020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Topchu I, Karnaukhov N, Mazitova A, Yugai
V, Voloshin M, Tikhomirova M, Kit O, Frantsiyants E, Kharin L,
Airapetova T, et al: Musashi 2 (MSI2) expression as an independent
prognostic biomarker in non-small cell lung cancer (NSCLC). J
Thorac Dis. 13:1370–1379. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen J, Shao J, Shen A, Zhu X, Zhang X,
Sun H, Wei S and Ling Y: Enhanced expression of FGF19 predicts poor
prognosis in patients with non-small cell lung cancer. J Thorac
Dis. 13:1769–1784. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang H, Jiang X, Cheng Y, Ren H, Hu Y,
Zhang Y, Su H, Zou Z, Wang Q, Liu Z, et al: MZT2A promotes NSCLC
viability and invasion by increasing Akt phosphorylation via the
MOZART2 domain. Cancer Sci. 112:2210–2222. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takahashi K and Nadal-Ginard B: Molecular
cloning and sequence analysis of smooth muscle calponin. J Biol
Chem. 266:13284–13288. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rami G, Caillard O, Medina I, Pellegrino
C, Fattoum A, Ben-Ari Y and Ferhat L: Change in the shape and
density of dendritic spines caused by overexpression of acidic
calponin in cultured hippocampal neurons. Hippocampus. 16:183–197.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Daimon E, Shibukawa Y and Wada Y: Calponin
3 regulates stress fiber formation in dermal fibroblasts during
wound healing. Arch Dermatol Res. 305:571–584. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shibukawa Y, Yamazaki N, Daimon E and Wada
Y: Rock-dependent calponin 3 phosphorylation regulates myoblast
fusion. Exp Cell Res. 319:633–648. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia L, Yue Y, Li M, Zhang YN, Zhao L, Lu
W, Wang X and Xie X: CNN3 acts as a potential oncogene in cervical
cancer by affecting RPLP1 mRNA expression. Sci Rep. 10:24272020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong KS, Kim H, Kim SH, Kim M and Yoo J:
Calponin 3 regulates cell invasion and doxorubicin resistance in
gastric cancer. Gastroenterol Res Pract. 2019:30249702019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nakarai C, Osawa K, Akiyama M, Matsubara
N, Ikeuchi H, Yamano T, Hirota S, Tomita N, Usami M and Kido Y:
Expression of AKR1C3 and CNN3 as markers for detection of lymph
node metastases in colorectal cancer. Clin Exp Med. 15:333–341.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dai F, Luo F, Zhou R, Zhou Q, Xu J, Zhang
Z, Xiao J and Song L: Calponin 3 is associated with poor prognosis
and regulates proliferation and metastasis in osteosarcoma. Aging
(Albany NY). 12:14037–14049. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Stearman RS, Dwyer-Nield L, Zerbe L,
Blaine SA, Chan Z, Bunn PA Jr, Johnson GL, Hirsch FR, Merrick DT,
Franklin WA, et al: Analysis of orthologous gene expression between
human pulmonary adenocarcinoma and a carcinogen-induced murine
model. Am J Pathol. 167:1763–1775. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Landi MT, Dracheva T, Rotunno M, Figueroa
JD, Liu H, Dasgupta A, Mann FE, Fukuoka J, Hames M, Bergen AW, et
al: Gene expression signature of cigarette smoking and its role in
lung adenocarcinoma development and survival. PLoS One.
3:e16512008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Schabath MB, Welsh EA, Fulp WJ, Chen L,
Teer JK, Thompson ZJ, Engel BE, Xie M, Berglund AE, Creelan BC, et
al: Differential association of STK11 and TP53 with KRAS
mutation-associated gene expression, proliferation and immune
surveillance in lung adenocarcinoma. Oncogene. 35:3209–3216. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sato M, Larsen JE, Lee W, Sun H, Shames
DS, Dalvi MP, Ramirez RD, Tang H, DiMaio JM, Gao B, et al: Human
lung epithelial cells progressed to malignancy through specific
oncogenic manipulations. Mol Cancer Res. 11:638–650. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okayama H, Kohno T, Ishii Y, Shimada Y,
Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S,
et al: Identification of genes upregulated in ALK-positive and
EGFR/KRAS/ALK-negative lung adenocarcinomas. Cancer Res.
72:100–111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tang Z, Kang B, Li C, Chen T and Zhang Z:
GEPIA2: An enhanced web server for large-scale expression profiling
and interactive analysis. Nucleic Acids Res. 47:W556–W560. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nair VA, Al-Khayyal NA, Sivaperumal S and
Abdel-Rahman WM: Calponin 3 promotes invasion and drug resistance
of colon cancer cells. World J Gastrointest Oncol. 11:971–982.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jiang X, Qin Y, Kun L and Zhou Y: The
significant role of the microfilament system in tumors. Front
Oncol. 11:6203902021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ediriweera MK, Tennekoon KH and Samarakoon
SR: Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer:
Biological and therapeutic significance. Semin Cancer Biol.
59:147–160. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang X, He X, Liu Y, Zhang H, Chen H, Guo
S and Liang Y: MiR-101-3p inhibits the growth and metastasis of
non-small cell lung cancer through blocking PI3K/AKT signal pathway
by targeting MALAT-1. Biomed Pharmacother. 93:1065–1073. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen H, Zhou L, Wu X, Li R, Wen J, Sha J
and Wen X: The PI3K/AKT pathway in the pathogenesis of prostate
cancer. Front Biosci (Landmark Ed). 21:1084–1091. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Martini M, De Santis MC, Braccini L,
Gulluni F and Hirsch E: PI3K/AKT signaling pathway and cancer: An
updated review. Ann Med. 46:372–383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang J, Cron P, Thompson V, Good VM, Hess
D, Hemmings BA and Barford D: Molecular mechanism for the
regulation of protein kinase B/Akt by hydrophobic motif
phosphorylation. Mol Cell. 9:1227–1240. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Calera MR, Martinez C, Liu H, Jack AK,
Birnbaum MJ and Pilch PF: Insulin increases the association of
Akt-2 with Glut4-containing vesicles. J Biol Chem. 273:7201–7204.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gao X, Wang N, Wu S, Cui H, An X and Yang
Y: Long noncoding RNA FER1L4 inhibits cell proliferation and
metastasis through regulation of the PI3K/AKT signaling pathway in
lung cancer cells. Mol Med Rep. 20:182–190. 2019.PubMed/NCBI
|
